← All trials
NCT04585035
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2020
- Primary completion
- Nov 30, 2022
- Completion date
- Feb 28, 2023
- First posted
- Oct 14, 2020
- Last posted
- Oct 27, 2020
- Enrollment
- 200
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- InventisBio Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.